ROTTINGHAUS SCOTT T. (Chief Medical Officer) received a stock award from ENANTA PHARMACEUTICALS INC
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 2 awards
Filed: 2/13/2026ACC: 0002064832-26-000010
Officer· Chief Medical Officer
Since Feb 2026
+3.46K
Net shares
Net buyer
$48.6K
Total sold
0
Open market trades
0B · 0S
3
Total transactions
6.88K acquired · 3.41K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
+1.65K
Price / share
—
Trade value
—
% of position
7.6%
2/12/2026
21.79K→23.44K
Common Stock
Direct
Shares
+5.22K
Price / share
—
Trade value
—
% of position
22.3%
2/12/2026
23.44K→28.67K
Common Stock
Direct
Shares
−3.41K
Price / share
$14.25
Trade value
$48.64K
% of position
11.9%
2/12/2026
28.67K→25.25K
Total
Net shares
+3.46K
Net value
-$48.64K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/12/2026 | A · Award | +1.65K | — | — | 7.6% | 21.79K | 23.44K |
| Common Stock Direct | 2/12/2026 | A · Award | +5.22K | — | — | 22.3% | 23.44K | 28.67K |
| Common Stock Direct | 2/12/2026 | F · Tax Withholding | −3.41K | $14.25 | $48.64K | 11.9% | 28.67K | 25.25K |
| Total | +3.46K | -$48.64K | ||||||
Derivative Transactions0
No derivative transactions reported